camostat has been researched along with Orthomyxoviridae Infections in 2 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Orthomyxoviridae Infections: Virus diseases caused by the ORTHOMYXOVIRIDAE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sato, K | 1 |
Hayashi, H | 1 |
Shimotai, Y | 1 |
Yamaya, M | 1 |
Hongo, S | 1 |
Kawakami, K | 1 |
Matsuzaki, Y | 1 |
Nishimura, H | 1 |
Lee, MG | 1 |
Kim, KH | 1 |
Park, KY | 1 |
Kim, JS | 1 |
2 other studies available for camostat and Orthomyxoviridae Infections
Article | Year |
---|---|
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Benzamidines; Cell Line; Cell Line, Tumor; Cells, Cu | 2021 |
Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.
Topics: Adaptation, Physiological; Amantadine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; | 1996 |